MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Invested Capital (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Invested Capital came in at $86145.0 in Q4 2017.

Analysis

MeiraGTx Holdings (MGTX) Invested Capital (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 1 years of Invested Capital data on file, last reported at $86145.0 in Q4 2017.

  • Quarterly Invested Capital changed N/A year-over-year to $86145.0 in Q4 2017, while the trailing twelve-month figure through Sep 2018 was $86145.0 (changed N/A YoY) and the FY2017 annual result came in at $86145.0, changed N/A from the prior year.
  • Invested Capital steadied at $86145.0 in Q4 2017.
  • In the past five years, Invested Capital ranged from a high of $86145.0 in Q4 2017 to a low of $86145.0 in Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 321.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 321.00 Mn
Dec 31, 2025 68.54 Mn
Sep 30, 2025 33.50 Mn
Jun 30, 2025 76.73 Mn
Mar 31, 2025 106.59 Mn
Dec 31, 2024 141.05 Mn
Sep 30, 2024 168.68 Mn
Jun 30, 2024 152.70 Mn
Mar 31, 2024 194.13 Mn
Dec 31, 2023 210.30 Mn
Sep 30, 2023 163.73 Mn
Jun 30, 2023 195.10 Mn
Mar 31, 2023 161.52 Mn
Dec 31, 2022 188.77 Mn
Sep 30, 2022 193.52 Mn
Jun 30, 2022 142.28 Mn
Mar 31, 2022 161.84 Mn
Dec 31, 2021 186.35 Mn
Dec 31, 2018 81.06 Mn
Sep 30, 2018 96.34 Mn